CTFA announces global forum
This article was originally published in The Rose Sheet
Executive Summary
Cosmetics, Toiletry and Fragrance Association signs agreement Feb. 27 to create a forum on global harmonization of regulations for cosmetics and personal care products. CTFA and its co-signers - COLIPA in Europe, CCTFA in Canada, and JCIA in Japan - have formally proposed the forum to the regulatory bodies within their respective governments. The forum will pave the way toward international alignment of cosmetics regulations; similar to the harmonization afforded other products such as drugs and medical devices. "We've had informal discussions with regulators in the United States, and I know our counterparts in other countries have done the same," CTFA Public Affairs Committee member Francine Gingras, director of external relations for Procter & Gamble Beauty, said during CTFA's annual meeting in Boca Raton, Fla. "We are hopeful that we will have good feedback soon from our regulators to this proposal and that this initiative will get underway in the coming year." The agreement is part of CTFA's strategy to support the global market for cosmetics and personal care products (1"The Rose Sheet" Jan. 1, 2007, p. 3). Over the last year, CTFA has worked on consumer protection, trade and industry growth issues in countries such as China, Japan and Russia...
You may also be interested in...
CTFA Prioritizes Globalization, FDA Funding Among Goals For 2007
The Cosmetic, Toiletry & Fragrance Association is launching an "ambitious" agenda for 2007, with global harmonization, FDA funding and member education listed as top priorities for the new year
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.